Search for: "David B. Holman"
Results 1 - 13
of 13
Sorted by Relevance
|
Sort by Date
28 Oct 2008, 5:35 pm
Articles Larry Alexander & Saikrishna B. [read post]
14 Feb 2012, 8:18 am
There, HHJ Holman applies his position developed from his judgment in Pinnock (at first instance) that the possession claim must be dismissed in the face of a successful public law defence (citing also Barber and Pinnock in the CA). [read post]
14 Feb 2012, 8:18 am
There, HHJ Holman applies his position developed from his judgment in Pinnock (at first instance) that the possession claim must be dismissed in the face of a successful public law defence (citing also Barber and Pinnock in the CA). [read post]
2 Oct 2018, 3:25 am
The now pending appeal is interesting and Natural Alternatives has garnered Amici support from both BIO and a group of leading patent law scholars that include Chris Holman (Drake and UMKC), David Lund (GMU), Adam Mossoff (GMU), Kristen Osenga (Richmond), and David Taylor (SMU). [read post]
9 Aug 2022, 5:53 pm
David Hricik. [read post]
27 Feb 2010, 3:07 am
Also testifying will be Transportation Secretary Ray LaHood, NHTSA administrator David Strickland and Yoshimi Inaba, Toyota's top North American executive. [read post]
30 Jul 2012, 5:00 am
Erichson Mass Tort Litigation Blog George Mason M David Bernstein Volokh Conspiracy George Mason M Ilya Somin Volokh Conspiracy George Mason M Josh Wright Truth on the Market George Mason M Todd Zywicki Volokh Conspiracy Georgetown F Rebecca Tushnet 43(B)log Georgetown M Lawrence B. [read post]
21 Dec 2009, 3:06 am
Glynn (Barry), David R. [read post]
15 Feb 2008, 9:00 am
: (Spicy IP),USD 20 billion going off-patent: (Patent Circle),Canadian Prices Review Board asserts jurisdiction over products sold in US, but imported into Canada under Special Access Program: (Gowlings),Canadian Court of Appeal affirms decision allowing patent-owner to be joined to proceedings: Cobalt v Pfizer and Pharmascience v Pfizer: (Gowlings),PharmaStem appeals stem cell patent: asks for greater deference to patent examiners: PharmaStem … [read post]
16 Jul 2022, 1:00 am
In a recent decision of the Court of Protection, Re SB (A patient; capacity to consent to termination) [2013] EWHC 1417 (COP) 21 May 2013, Mr Justice Holman held that it had not been established that a woman, SB, undergoing treatment for bipolar disorder lacked capacity to make decisions about her desire to terminate her pregnancy and stated that he would either make a declaration to that effect or dismiss the proceedings. [read post]
31 May 2022, 6:43 am
Meanwhile, further down the judicial corridor, Holman J took a different view. [read post]
15 Dec 2020, 8:30 am
Levin (Georgia), Dean Lyrissa Lidsky (Missouri), Clare Norins (Georgia), David F. [read post]
22 Mar 2008, 2:00 am
: (IPBiz),US: Two remaining challenged WARF embryonic stem cell patents upheld in ex parte reexamination: (Holman's Biotech IP Blog), Pharma & Biotech - ProductsAricept (Donepezil) – USV wins appeal against USPTO decision: (Spicy IP),Celerex (Celecoxib) – CAFC decision in Celebrex patents dispute between Pfizer and Teva will cut patent term by one and a half years: (Patent Baristas), Inersan – Ranbaxy in-licenses Inersan to CD Pharma to market in… [read post]
